Advice
Following a full submission
esomeprazole (Nexium I.V.®) is accepted for use within NHS Scotland for prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers.
In patients with high-risk peptic ulcer bleeding, high-dose intravenous esomeprazole significantly reduced recurrent bleeding at 72 hours compared to placebo.
Download detailed advice87KB (PDF)
Medicine details
- Medicine name:
- esomeprazole IV 40mg powder (Nexium)
- SMC ID:
- 578/09
- Indication:
- Prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers.
- Pharmaceutical company
- AstraZeneca UK Ltd
- BNF chapter
- Gastro-intestinal system
- Submission type
- Full
- Status
- Accepted
- Date advice published
- 09 November 2009